newco – Talk Bio

Actionable Insights Powered by AI

Aditum forms new company for China-sourced asset in $1B deal

1 month ago talkbio0Tagged Aditum, biotech licensing, China-sourced asset, cross-border pharma, Dyslipidemias, Mabwell, newco, Vascular Diseases

Aditum; China-sourced asset; $1B deal; newco; Mabwell; dyslipidemia; vascular disorders; biotech licensing; cross-border pharma

BridgeBio Launches KRAS-Targeted Cancer Startup with $200 Million in Venture Capital Funding

1 year ago talkbio0Tagged BridgeBio, cellular targeting, K-ras Oncogene, Neoplasms, newco, Precision Medicine, startup, venture

BridgeBio, KRAS, cancer, startup, venture capital, funding, newco, oncology, precision medicine, targeted therapies.